oemine biolin
Food supplement declared in France, declaration No 2023-4-828
oemine biolin (oemine) is a food supplement declared in France. Status: retiré du marché le 17 September 2026. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- oemine
- Food business operator placing the product on the market
- PHYTOBIOLAB
- Status
- Retiré du marché le 17 September 2026
- Form
- Capsule
- Daily dose
- 2 à 8 capsule par jour
- Directions for use
- 4 capsule matin et soir
- Not recommended for (according to the manufacturer)
- Antécédent de cancer du sein, Enfants (de moins de 10 ans)
- Objectives stated by the manufacturer (these are not authorised claims)
- Artères et cholestérol
Declaration 193615, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Retiré du marché le 17 September 2026, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Linum usitatissimum L. | Graine (huile) | Pression à froid | 4,000 mg |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Mélange de tocophérols | Vitamine E | 300 mg | 30 mg |
Other ingredients
Gélatine marine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Déconseillé chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein. Déconseillé chez l'enfant de moins de 10 ans
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- oemine bio lin oemine, declared in 2023 : different composition: 1 ingredient(s) added, 1 missing
Brand : oemine